It’s Monday, the second day of October trading, and I have the perfect game plan to get us through the week — it benefits from the news bomb about Merck’s new antiviral pill for COVID-19.
September was not a great month for investors… We saw the S&P 500 trade down 4.76% while the Nasdaq fell over 5%.
The Russell 2000 sank 3.06% and the beloved Cathie Wood fund, ARK Innovation ETF (NYSEArca: ARKK), tanked almost 10%.
The VIX, or volatility index, exploded by about 44% — which I expect to go even higher in the fall (it’s up another 12% through Monday afternoon) — and the 10-year Treasury yield went back above the 150 level (or 1.5%).
The first trading session for October, this past Friday, made up for it…
Merck’s Antiviral Pill for COVID-19 Causes Breakouts in These Names
On Oct. 1, Merck & Co. Inc. (NYSE: MRK) came out with a game changer for the entire global economy, and the stock gapped up accordingly.
The big pharmacy giant saw its shares rise by 9% ahead of the opening bell that morning.
Merck has been developing an antiviral pill, molnupiravir, people can take orally that’ll cut the likelihood of getting hospitalized for COVID-19 by about half.
That’s huge news — and a solid reason why the shares keep rising.
And it’s already affecting other areas on the stock market.
Looking at the travel stock names, like American Airlines Group Inc. (Nasdaq: AAL) and Marriott International Inc. (Nasdaq: MAR), you’ll notice that it’s already helping cause moves to the upside.
And I expect more breakouts to happen soon.
October is going to be all about playing the reopening names as Merck’s announcement boosts investor sentiment on our recovering economy.
But I also expect some extreme selling in technology to continue throughout this month, and for oil to make new highs.
Luckily, on Tuesday I’m releasing nine — yes, nine — new trades I put together that should allow us to profit in October, no matter what the stock market conditions become…
Make sure you receive this exclusive trade alert by clicking here.
Check out the video below to learn more about my October trading game plan and Merck’s new antiviral pill for COVID-19.
Send any trading questions to firstname.lastname@example.org and stay ahead of the markets, especially these choppy ones, by subscribing to our YouTube channel.